Pharmacokinetics and pharmacodynamics of 'old'polymyxins: what is new?
'Old'colistin and polymyxin B are increasingly used as last-line therapy against multidrug-
resistant Gram-negative bacteria Pseudomonas aeruginosa, Acinetobacter baumannii, and …
resistant Gram-negative bacteria Pseudomonas aeruginosa, Acinetobacter baumannii, and …
Pharmacokinetics and pharmacodynamics of'old'polymyxins: what is new?
PJ Bergen, CB Landersdorfer, J Zhang… - Diagnostic …, 2012 - europepmc.org
Abstract 'Old'colistin and polymyxin B are increasingly used as last-line therapy against
multidrug-resistant Gram-negative bacteria Pseudomonas aeruginosa, Acinetobacter …
multidrug-resistant Gram-negative bacteria Pseudomonas aeruginosa, Acinetobacter …
[PDF][PDF] Pharmacokinetics and pharmacodynamics of 'old'polymyxins: what is new?
PJ Bergen, CB Landersdorfer, J Zhang… - … Microbiol Infect Dis, 2012 - academia.edu
Abstract 'Old'colistin and polymyxin B are increasingly used as last-line therapy against
multidrugresistant Gram-negative bacteria Pseudomonas aeruginosa, Acinetobacter …
multidrugresistant Gram-negative bacteria Pseudomonas aeruginosa, Acinetobacter …
Pharmacokinetics and pharmacodynamics of'old'polymyxins: what is new?
PJ Bergen, CB Landersdorfer, ZJ Zhang Jing… - 2012 - cabidigitallibrary.org
Abstract'Old'colistin and polymyxin B are increasingly used as last-line therapy against
multidrug-resistant Gram-negative bacteria Pseudomonas aeruginosa, Acinetobacter …
multidrug-resistant Gram-negative bacteria Pseudomonas aeruginosa, Acinetobacter …
Pharmacokinetics and pharmacodynamics of'old'polymyxins: What is new?
PJ Bergen, CB Landersdorfer, J Zhang… - Diagnostic …, 2012 - research.monash.edu
Old colistin and polymyxin B are increasingly used as last-line therapy against multidrug-
resistant Gram-negative bacteria Pseudomonas aeruginosa, Acinetobacter baumannii, and …
resistant Gram-negative bacteria Pseudomonas aeruginosa, Acinetobacter baumannii, and …
[引用][C] Pharmacokinetics and pharmacodynamics of'old'polymyxins: what is new?
PJ BERGEN - Diagn. Microbiol. Infect. Dis., 2012 - cir.nii.ac.jp
[引用][C] Pharmacokinetics and pharmacodynamics of'old'polymyxins: what is new?
PJ BERGEN, CB LANDERSDORFER… - Diagnostic …, 2012 - pascal-francis.inist.fr
Pharmacokinetics and pharmacodynamics of 'old' polymyxins: what is new? CNRS Inist
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …
Pharmacokinetics and pharmacodynamics of'old'polymyxins: what is new?
PJ Bergen, CB Landersdorfer… - Diagnostic …, 2012 - pubmed.ncbi.nlm.nih.gov
'Old'colistin and polymyxin B are increasingly used as last-line therapy against multidrug-
resistant Gram-negative bacteria Pseudomonas aeruginosa, Acinetobacter baumannii, and …
resistant Gram-negative bacteria Pseudomonas aeruginosa, Acinetobacter baumannii, and …
Pharmacokinetics and pharmacodynamics of 'old'polymyxins: what is new?
PJ Bergen, CB Landersdorfer, J Zhang, M Zhao… - … & Infectious Disease, 2012 - infona.pl
'Old'colistin and polymyxin B are increasingly used as last-line therapy against multidrug-
resistant Gram-negative bacteria Pseudomonas aeruginosa, Acinetobacter baumannii, and …
resistant Gram-negative bacteria Pseudomonas aeruginosa, Acinetobacter baumannii, and …
[HTML][HTML] Pharmacokinetics and pharmacodynamics of 'old'polymyxins: what is new?
PJ Bergen, CB Landersdorfer, J Zhang… - Diagnostic …, 2012 - ncbi.nlm.nih.gov
Abstract 'Old'colistin and polymyxin B are increasingly used as last-line therapy against
multidrug-resistant Gram-negative bacteria Pseudomonas aeruginosa, Acinetobacter …
multidrug-resistant Gram-negative bacteria Pseudomonas aeruginosa, Acinetobacter …